Sign in to follow this  
Followers 0
Altostrata

2009: FDA hears testimony about Cymbalta discontinuation syndrome

8 posts in this topic

NOTE Also see

 

Study finds some Cymbalta withdrawal "severe and persistant"
 
Doctor is shocked at severe Cymbalta withdrawal symptoms

 

Cymbalta Withdrawal Lawsuits Progressing in US

 

Tips for tapering off Cymbalta (duloxetine)

 


 

This presentation was part of the June 9, 2009 meeting minutes of the FDA Psychopharmacologic Drugs Advisory Committee meeting in Maryland. It contains many anecdotal reports of severe and long-lasting withdrawal syndrome from Cymbalta, a relatively new wonder drug.

Pdf at http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM172866.pdf or http://www.mediafire.com/?hfigc5c6c04ekki

About the FDA Psychopharmacologic Drugs Advisory Committee: http://google2.fda.gov/search?q=Psychopharmacologic+Drugs+Advisory+Committee&x=6&y=10&client=FDAgov&site=FDAgov&lr=&proxystylesheet=FDAgov&output=xml_no_dtd&getfields=*

From the presentation to the FDA
 

Much anecdotal evidence has accumulated documenting the
injury, distress and life management impacts caused by
discontinuation of Cymbalta
The effects of discontinuation can be severe and extend for weeks or
even months

  • Extreme mood swings (anger, irritability)
  • Debilitating “Brain Zaps”
  • Physical and neurological problems
– Physical and psychological disturbances adversely affect job function
and family/social relationships
  • Employment risk
  • Negative impacts on care of family members
Edited by Altostrata
updated

Share this post


Link to post
Share on other sites

According to this article, Cymbalta is even worse than PAxil. I can hardly imagine a hell with even more scorching temperature as I went through... and that for years.

Good thing that the FDA has gotten access to this report. But I have little confidence that it will lead to appropriate action. The remarks about tapering are most important, the leaflets these days do contains warnings about the need for tapering off, but none of the manufacturers delivers a working scheme in the leaflet or refers to use of the liquid...

Share this post


Link to post
Share on other sites

Sorry, this topic was closed by mistake. Post on!

Share this post


Link to post
Share on other sites

Is there a link to another version of that file? I can't open files at that site. :( I'd be fascinated to read the document, even though I'm not on that drug.

B

Share this post


Link to post
Share on other sites

Put this in Google:

 

Cymbalta (Duloxetine) Discontinuation Syndrome www.fda.gov

 

It is the search result on www.fda.gov, a pdf download

Edited by Altostrata
fixed text

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!


Register a new account

Sign in

Already have an account? Sign in here.


Sign In Now
Sign in to follow this  
Followers 0